Showing posts with label
gene editing
.
Show all posts
Showing posts with label
gene editing
.
Show all posts
Tuesday, June 25, 2024
Going forward, how viable is Beam Therapeutics in the BioTech market?
›
Fr: ChatGPT Beam Therapeutics appears to be a viable biotechnology company, with several strengths that contribute to its potential: Finan...
Thursday, June 20, 2024
Illumina's strong market position in the genomics and life sciences sectors, positive return on equity, recent insider buying and Ai applications signal confidence in its future
›
Illumina Inc. (NASDAQ: ILMN), has several positive indicators for the company's prospects going forward. Analyst Ratings and Price Targ...
1 comment:
Friday, May 10, 2024
Can two small caps become the kings of synthetic biology? Only time will tell!
›
Both Twist Biosciences and Ginkgo Bioworks are prominent players in the field of Synthetic biology , but they have different focus...
›
Home
View web version
